Albuterol Dosing Guidelines for Pediatric Patients
Introduction to Albuterol Dosing
- The American Academy of Pediatrics recommends administering albuterol nebulizer solution 0.63 mg (diluted in 3 mL of saline) for routine bronchodilator therapy in children under 5 years of age 1
- For acute exacerbations, weight-based dosing of 0.15 mg/kg (minimum 2.5 mg) is preferred, administered every 20 minutes for 3 doses, then every 1-4 hours as needed 2, 3
Routine Maintenance Dosing
- For children under 5 years of age, the standard dose is 0.63 mg/3 mL via nebulizer, which is FDA-approved for young children and represents the safest starting point for routine bronchodilator therapy 1
- The solution should be diluted to a minimum of 3 mL total volume for optimal nebulization 2, 3
Acute Exacerbation Dosing
- Administer 0.15 mg/kg (minimum dose 2.5 mg) every 20 minutes for the first 3 doses for acute asthma exacerbations or severe wheezing 2, 3, 4
- For a typical 1-year-old weighing approximately 10 kg, the minimum dose of 2.5 mg should be used since the calculated dose falls below the established minimum 3, 4
- After the initial 3 doses, continue with 2.5 mg every 1-4 hours as needed based on clinical response 2, 3
Severe Exacerbations
- For continuous nebulization in life-threatening cases, use 0.5 mg/kg/hour 3, 4
- Add ipratropium bromide 0.25 mg to the first 3 albuterol doses for moderate-to-severe exacerbations 2, 3
Administration Technique
- Always use a properly fitted face mask that covers both nose and mouth snugly 5
- Dilute the albuterol dose to at least 3 mL with normal saline for optimal aerosol delivery 2, 3, 4
- Use oxygen as the driving gas when available, particularly in hypoxic patients 3
- Only use jet nebulizers; ultrasonic nebulizers are ineffective for albuterol solutions 5
Alternative: MDI with Spacer
- For mild-to-moderate exacerbations, an MDI with valved holding chamber (spacer) and face mask can be equally effective as nebulized therapy 2, 3, 4
- Administer 4-8 puffs (90 mcg/puff = 360-720 mcg total) every 20 minutes for 3 doses 2
Monitoring and Safety
- Monitor closely for adverse effects, especially with frequent dosing, including tachycardia, tremor, hypokalemia, and hyperglycemia 1, 2, 3
- Response to treatment is a better predictor of need for hospitalization than initial severity, so reassess after each treatment cycle 2